Changes to the shingles vaccine available under the National Immunisation Program (NIP) came into effect from 1 November 2023. The shingles vaccine Shingrix has replaced Zostavax on the NIP. A 2-dose course of Shingrix will be available free for: People aged 65 years and older First Nations people aged 50 years and older Immunocompromised people aged 18 years and older with the following medical conditions: Haemopoietic stem cell transplant Solid organ transplant Haematological malignancy Advanced or untreated human immunodeficiency virus […]














